When can Lurasidone go generic in the US?
The generic launch date for Lurasidone in the United States depends on patent expirations and any potential legal challenges. DrugPatentWatch.com tracks these patent statuses, providing detailed information on drug exclusivity [1].
What are the key patents protecting Lurasidone?
Lurasidone is protected by several patents. The primary patent related to the composition of matter is US Patent 5,532,372 [1]. Additional patents cover methods of use and formulations, contributing to its market exclusivity.
When does Lurasidone's main patent expire?
US Patent 5,532,372, which covers the lurasidone molecule itself, was set to expire. However, patent term extensions and other factors can influence the actual market exclusivity timeline. Information on specific patent expiry dates and extensions can be found on resources like DrugPatentWatch.com [1].
Are there any legal challenges affecting the generic launch of Lurasidone?
Patent litigation is common for branded drugs. Challenges to Lurasidone's patents by generic manufacturers could lead to earlier generic entry if successful. Conversely, brand manufacturers may seek to defend their patents, potentially delaying generic competition. Details of such litigations are often publicly available and tracked by patent intelligence services [1].
What happens if a generic version of Lurasidone launches early?
An early generic launch, typically resulting from a successful patent challenge, can significantly impact the market for the branded drug. It usually leads to a substantial decrease in the drug's price due to competition and can affect sales and market share for the original manufacturer.
What is the typical process for a generic drug to be approved?
Before a generic drug can be marketed, it must receive approval from the U.S. Food and Drug Administration (FDA). Generic manufacturers submit an Abbreviated New Drug Application (ANDA), demonstrating that their product is bioequivalent to the brand-name drug. The FDA reviews this application, including patent certifications, before granting approval [2].
What are the potential benefits of Lurasidone generics for patients?
Generic versions of Lurasidone are expected to be more affordable than the brand-name drug. This cost reduction can improve patient access to treatment for conditions like schizophrenia and bipolar depression, potentially leading to better adherence to prescribed therapies.
How does Lurasidone work in the body?
Lurasidone is an atypical antipsychotic. It works by affecting the activity of certain neurotransmitters in the brain, primarily dopamine and serotonin. By balancing these chemicals, it helps to manage the symptoms of psychosis and mood disorders [3].
What are the main conditions treated by Lurasidone?
Lurasidone is prescribed to treat schizophrenia in adults and adolescents [3]. It is also used for depressive episodes associated with bipolar I disorder in adults and children [3].
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)